[1]
Pan, Y. and Yu, Z. 2025. Progress and Prospects of Interleukin-22 in the Treatment of Non-alcoholic Fatty Liver Disease. Journal of Contemporary Medical Practice. 7, 1 (Jan. 2025), 95–99. DOI:https://doi.org/10.53469/jcmp.2025.07(01).19.